about
To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic CardiomyopathyImaging in the management of ischemic cardiomyopathy: special focus on magnetic resonanceLong-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention.Physiology of Angina and Its Alleviation With Nitroglycerin: Insights From Invasive Catheter Laboratory Measurements During Exercise.SLE with recurrent heart failure and a dermatological clue to another added possibilityMyocardial feature tracking reduces observer-dependence in low-dose dobutamine stress cardiovascular magnetic resonanceDoes a well developed collateral circulation predispose to restenosis after percutaneous coronary intervention? An intravascular ultrasound study.A quantitative high resolution voxel-wise assessment of myocardial blood flow from contrast-enhanced first-pass magnetic resonance perfusion imaging: microsphere validation in a magnetic resonance compatible free beating explanted pig heart model.Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease.Effects of Epicardial and Endocardial Cardiac Resynchronization Therapy on Coronary Flow: Insights From Wave Intensity Analysis.Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease.Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction.The balloon pump-assisted coronary intervention study (BCIS-1): rationale and design.Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease.Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013.Virtual fractional flow reserve by coronary computed tomography - hope or hype?Intraaortic balloon pump use in high-risk percutaneous coronary intervention.Intra-aortic balloon pump for high-risk percutaneous coronary intervention.Successful treatment of ST elevation myocardial infarction caused by septic embolus with the use of a thrombectomy catheter in infective endocarditis.Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial.Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.Physiological Assessment of Left Main Coronary Artery Disease.Usefulness of Intra-aortic Balloon Pump Counterpulsation.Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.Percutaneous mechanical circulatory support: current concepts and future directions.A Randomised tRial of Expedited transfer to a cardiac arrest centre for non-ST elevation ventricular fibrillation out-of-hospital cardiac arrest: The ARREST pilot randomised trial.The assessment of ischaemic burden: validation of a functional jeopardy score against cardiovascular magnetic resonance perfusion imaging.Implementation and consistency of Heart Team decision-making in complex coronary revascularisation.The impact of processes of care on myocardial infarct size in patients with ST-segment elevation myocardial infarction: observations from the CRISP-AMI trial.Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.Pharmacological vasodilatation in the assessment of pressure-derived collateral flow index.Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy.The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is independent of field strength.Prognostic utility of BCIS myocardial jeopardy score for classification of coronary disease burden and completeness of revascularization.Intra-aortic balloon pump trials: questions, answers, and unresolved issues.Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction or Stable Angina Pectoris.Contrast-enhanced magnetic resonance imaging for the detection of ruptured coronary plaques in patients with acute myocardial infarction.Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial.A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: rationale and design of the Counterpulsation RedSTICH: resoundingly negative or a signal of benefit? Where next for revascularization in ischemic cardiomyopathy?
P50
Q26749674-8D32ED2C-7830-4061-B47B-F73BDC29BE8CQ26824350-79336D67-F263-4F91-9181-8A1B10D52F72Q30580763-5898BCC8-15A1-4F1F-A0E1-7CD4F3BF0E14Q33853633-409CED8C-3E98-416D-9080-FB25BF5EC183Q34816370-974F6574-C9E6-4A32-9662-F2970A3C3A17Q35304674-A0032B24-01F9-4C0C-BED4-36E119E86B3DQ35770892-FACD43AA-71A8-48A8-AA6C-967A9311851DQ36061574-33F8BD28-1487-4758-A881-555ECD557A9AQ36061574-4A3D3168-7008-4890-83A6-0668C68770DDQ36498991-0668D403-0720-4E06-9F5A-EAB053BFF189Q36836456-493904AA-CFF1-48FF-A628-C2C53C4BF8BFQ37105989-F2ADF0F6-02E2-4613-A380-C4AE4DDBD211Q37322418-827F5020-4C84-42EB-9BD8-D665BABD24D3Q37643911-1D56405C-F643-4C65-ABF3-C20447199217Q37779678-64F8560E-9C8B-4B0A-B72C-1769FFDCDCDDQ38106501-C200234A-256E-4E11-BE25-558DF9CD07AEQ38116377-A4FA4DFD-D79D-4D4B-8152-FDA63EB352DFQ38146753-82F3932C-C9AA-44C2-98DD-A56F05E3B944Q38261897-0549FCC7-2758-451F-BDE5-56291465149EQ38371094-4061FA2F-D742-4C22-B096-B3E9126F3F46Q38485558-D739030A-B3F2-4FA9-B572-2069FA931944Q38500777-D6040480-CF02-445C-B3C9-08B0EEF089CEQ38671743-35A7FE9E-E5F8-4AC4-B3D5-984645A08260Q38680733-7D527024-5158-49D4-93B4-A96073D7F5BBQ38689158-FDA7B3B5-098C-453C-89DD-92515AD28A59Q38833101-83CE5BA4-3F9E-4601-BDC2-F3B09BAA7CB3Q38973481-1962777C-8FC2-4DDE-B750-9731CF7DAAD9Q39264252-A9FEEE0E-4E0A-40D3-9D97-5B456C2380B9Q40100014-B8C6C489-4CB8-482A-A119-B296A8FDFF10Q41714174-710A4089-88BF-4B1D-BB64-A4266077C2C3Q41928747-BEBCC687-34EC-49F7-81FD-8F4BD6732AE1Q42830815-CFC55512-1F23-407D-AF3E-B7286A153817Q43410572-C1AB9138-5F1A-4848-94AB-8FF6155E8144Q43705006-6855AC7A-D569-4234-AFC0-ADA065B614B3Q45376731-21B79F29-3517-443A-877E-CA80789F7463Q46110598-0C5B50F6-0C68-47CC-ACFF-6D49E8305C9AQ47095252-9952A827-06C8-4FF3-879B-2D955139D06BQ47161794-6F57D9D7-E5ED-4012-8BEE-FF83BF4A7BB8Q47317089-D60E3142-B72E-4A4B-B64B-4F3D95F36B95Q47367084-3628B47F-2965-4A06-AB41-FE0EAFF7E213
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Divaka Perera
@ast
Divaka Perera
@en
Divaka Perera
@es
Divaka Perera
@nl
Divaka Perera
@sl
type
label
Divaka Perera
@ast
Divaka Perera
@en
Divaka Perera
@es
Divaka Perera
@nl
Divaka Perera
@sl
prefLabel
Divaka Perera
@ast
Divaka Perera
@en
Divaka Perera
@es
Divaka Perera
@nl
Divaka Perera
@sl
P106
P21
P31
P496
0000-0001-6362-1291